Table of Contents
There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations - Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the in IVD industry as it applies to emerging markets and the BRIC countries in particular.
A Realistic Look at the Market for IVD in New, Emerging Markets
A good number of reports on the BRIC and emerging markets have been published. Most of these focus on quantitative data such as number of labs, hospitals, product registration regulations, and import taxes and conditions. Too many of them perhaps present merely a growth scenario without presenting the challenges the nations face and the challenges the countries face entering the market. This report provides much of this information because it provides an objective overview of the market for in vitro diagnostics in selected countries. This report also explores the opportunities that specific developing countries offer to IVD companies.
Kalorama also attempts to add some realistic aspects of working in a foreign country that are more qualitative in nature. Thus the report explores some of the cultural aspects of how the market for clinical diagnostics may evolve in a selection of emerging markets including the BRIC countries.
Useful Information for Business Planning
The discussion of each of the BRIC markets begins with a short introduction to the country and follows with a SWOT analysis of the market for IVDs. The SWOT analysis provides positive and negative aspects of market conditions. The author has decided to include positive and negative aspects of certain factors in the same SWOT category. The factors are classed positive or negative according to the strength of current market conditions. This is done to make the analysis comprehensive and easier to read.
The report covers data trends and issues, including:
Find all the market research you need - instantly, in one place.
Talk to Louis
+1 718 618 4302
“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...
Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...
Slowing US and European Markets Demand Alignment with Global Market Needs Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of ...
Reportlinker.com © Copyright 2014. All rights reserved.